Bio-Techne Corp.
$47.94
USD
Last updated on --.
24h volume279.00
24h highest49.1950 USD
24h lowest47.6660 USD
24h Price movement-0.06%
TECH recent prices
24 Hours
-0.06%-$0.03
30 days
-13.01%-$7.170
60 days
-5.35%-$2.725
90 days
-17.23%-$9.980
Key data
Previous close47.9700 USD
Market cap7.31B USD
Volume279.00
P/E ratio66.740000
Dividend yield (TTM)0.01%
Dividend amount0.080000 USD
Next ex-dividend dateMay 18, 2026
Next payment dateMay 29, 2026
EPS diluted (TTM)0.70000 USD
Net income (FY)109.56M USD
Revenue (FY)1.21B USD
Last report dateMay 6, 2026
About Bio-Techne Corp.
HeadquartersMINNEAPOLIS
Employees (FY)3.10K
Revenue per employee (FY)390.58K USD
Net income per employee (FY)35.34K USD
Listed onNasdaq
TECH conversion tables
 |  |
|---|---|
| 0.5 TECH | 23.97 USD |
| 1 TECH | 47.94 USD |
| 5 TECH | 239.7 USD |
| 10 TECH | 479.4 USD |
| |
|---|---|
| 0.5 USD | 0.01043 TECH |
| 1 USD | 0.020859 TECH |
| 5 USD | 0.1043 TECH |
| 10 USD | 0.20859 TECH |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
TECH is trading at $47.94, -0.06% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TECH stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TECH is currently trading at $47.94, -0.06% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TECH price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TECH's P/E ratio is currently 66.740000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TECH; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TECH's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Bio-Techne Corp.'s market cap is currently 7.31B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume279.00
24h highest49.1950 USD
24h lowest47.6660 USD
24h Price movement-0.06%
Start trade with TECH Perpetual
Sign up to trade